ALOX15 and chronic kidney disease: Conversely, the increase in L-PGDS and H-PGDS under 5/6 Nx conditions was significantly inhibited in Alox15−/− mice (Fig. 8a) indicating that the increase in PGD2 in Alox15−/− CKD model mice was not due to increased production by PGDS.